‘Welfare reforms could force 600,000 off incapacity benefit’, The Guardian, 8 November 2011
From The Guardian, 8 November 2011 (story by economics editor […]
‘Dr Ian Lipkin and Dr Mady Hornig use deep sequencing and proteomics to hunt CFS viruses’, Cure talk website, 4 November 2011
From the ‘Cure Talk: conversations about new treatments and clinical
Osborne and Clegg fight it out over alleged Tory plan to erode benefits, The Independent, 4 November 2011
From The Independent, 4 November 2011 (story by political editor
Parliamentary Question: national commissioning of treatment for M.E., 3 November 2011
Parliamentary Question: national commissioning of treatment for M.E., 3 November 2011 Read More »
A question asking the Secretary of State for Health what
TGI Friday! Our weekly round-up of research abstracts not yet published at this website
TGI Friday! Our weekly round-up of research abstracts not yet published at this website Read More »
Our regular Friday feature of summaries from research papers that
‘The stress of life takes its toll’, The Daily Telegraph, 3 November 2011
‘The stress of life takes its toll’, The Daily Telegraph, 3 November 2011 Read More »
From The Daily Telegraph, 3 November 2011 (story by Robert
‘Helping my sick daughter die was worst heartbreak a mother can face’, Evening Herald, Ireland, 2 November 2011
From the Evening Herald, Ireland, 2 November 2011 (story by
Research: social support needs of people with ME/CFS, 2 November 2011
Research: social support needs of people with ME/CFS, 2 November 2011 Read More »
From the International Journal for Equity in Health,10:46 doi:10.1186/1475-9276-10-46, 2
Fluge and Mella respond to van de Meer about rituximab, letter to PlosOne, 31 October 2011
From PlosOne, 31 October, where the full range of letters
‘Rituximab basics with Dr John Sweetenham’, Research 1st website, 30 October 2011
‘Rituximab basics with Dr John Sweetenham’, Research 1st website, 30 October 2011 Read More »
From ‘Research 1st’, a website maintained by the CFIDS Association
Concerns about rituximab study, letters to PloSOne, 27 October 2011
Concerns about rituximab study, letters to PloSOne, 27 October 2011 Read More »
Original paper in PLoSOne, 27 October 2011. Rituximab in CFS;
TGI Friday! Our weekly round-up of unreported research abstracts, 29 October 2011
TGI Friday! Our weekly round-up of unreported research abstracts, 29 October 2011 Read More »
Our regular Friday roundup of research abstracts that have not
Research: Literature review of complementary and alternative medicine used in ME/CFS, 7 October 2011
From BMC Complementary and Alternative Medicine, 7 October 2011. Complementary
Scottish Parliament Answers to Kezia Dugdale MSP, 26 October 2011
Scottish Parliament Answers to Kezia Dugdale MSP, 26 October 2011 Read More »
Kezia Dugdale, Scottish Labour MSP for Lothian, received answers to
UK insurance industry gets to hear about the rituximab clinical trial, 26 October 2011
UK insurance industry gets to hear about the rituximab clinical trial, 26 October 2011 Read More »
From USay Compare, Health Insurance News, 26 Octoberr 2011 Health
‘Government reforms to the WCA start to show results’, eGov monitor, 26 October 2011
‘Government reforms to the WCA start to show results’, eGov monitor, 26 October 2011 Read More »
From eGov monitor – a Policy Dialogue Platform, 26 October
‘CFS – a treatable autoimmune disease’, Huffington Post Online, 26 October 2011
‘CFS – a treatable autoimmune disease’, Huffington Post Online, 26 October 2011 Read More »
From Huffington Post Online, AOL Health News, 26 October 2011
‘Rituximab and the Press’, the CFS Patient Advocate blog, 24 October 2011
‘Rituximab and the Press’, the CFS Patient Advocate blog, 24 October 2011 Read More »
From the blog run by the ‘CFS Patient Advocate’, 24
ABC News in the States cover the Rituximab story, 24 October 2011
ABC News in the States cover the Rituximab story, 24 October 2011 Read More »
From ABC News, 24 October 2011 (story by Katie Moisse)
‘Scientists say XMRV poses no risk to blood supply’, Wall Street Journal health blog, 24 October 2011
From the Wall Street Journal health blog, 24 October, 2011